Comparison of the effectiveness of surgical treatment of uterine fibroids (literature review)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In review describes the possibilities, advantages and disadvantages of various types of surgical treatment of uterine fibroids, based on the latest evidence-based medicine regarding their effectiveness and safety.

Full Text

Restricted Access

About the authors

V. A. Kaptilnyy

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Author for correspondence.
Email: rtchilova@gmail.com
ORCID iD: 0000-0002-2656-132X

Associate Professor, Candidate of Medical Sciences

Russian Federation

M. V. Poznyak

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0006-8217-0784
Russian Federation

R. A. Chilova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0001-6331-3109

Professor, MD

Russian Federation

D. V. Lystsev

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0006-3826-3174
Russian Federation

E. A. Svidinskaya

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0002-2368-1932

Candidate of Medical Sciences

Russian Federation

K. A. Budnikova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0003-3644-2292

Candidate of Medical Sciences

Russian Federation

G. F. Proklova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0000-0003-3382-026X

Candidate of Medical Sciences

Russian Federation

T. G. Manucheva

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0003-8907-1090
Russian Federation

Z. M. Kokhreidze

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0004-4339-2558
Russian Federation

G. E. Sevastyanov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID iD: 0009-0000-4823-9510
Russian Federation

References

  1. Mas A., Tarazona M., Dasi Carrasco J. et al. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017; 9: 607–17. doi: 10.2147/IJWH.S138982
  2. Gurusamy K.S., Vaughan J., Fraser I.S. et al. Medical Therapies for Uterine Fibroids – A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. PLoS One. 2016; 11 (2): e0149631. doi: 10.1371/journal.pone.0149631
  3. Lee S.M., Choi E.S., Ha E. et al. Gyejibongnyeong-Hwan (Gui Zhi Fu Ling Wan) Ameliorates Human Uterine Myomas Via Apoptosis. Front Pharmacol. 2019; 10: 1105. doi: 10.3389/fphar.2019.01105
  4. Verpalen I.M., Anneveldt K.J., Nijholt I.M. et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis. Eur J Radiol. 2019; 120: 108700. doi: 10.1016/j.ejrad.2019.108700
  5. Liu L., Wang T., Lei B. High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for the treatment of symptomatic uterine fibroids: a meta-analysis. Eur Radiol. 2022; 32 (2): 1195–204. doi: 10.1007/s00330-021-08156-6
  6. Liu L., Wang T., Lei B. Ultrasound-guided Microwave Ablation in the Management of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021; 28 (12): 1982–92. doi: 10.1016/j.jmig.2021.06.020
  7. Liu L., Wang T., Lei B. Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2021; 28 (2): 218–27. doi: 10.1016/j.jmig.2020.11.004
  8. Li F., Chen J., Yin L. et al. HIFU as an alternative modality for patients with uterine fibroids who require fertility-sparing treatment. Int J Hyperthermia. 2023; 40 (1): 2155077. doi: 10.1080/02656736.2022.2155077
  9. Kohi M.P., Spies J.B. Updates on Uterine Artery Embolization. Semin Intervent Radiol. 2018; 35 (1): 48–55. doi: 10.1055/s-0038-1636521
  10. Donnez J., Donnez O., Dolmans M.M. The current place of medical therapy in uterine fibroid management. Best Pract Res Clin Obstet Gynaecol. 2018; 46: 57–65. doi: 10.1016/j.bpobgyn.2017.10.008
  11. Llewellyn O., Patel N.R., Mallon D. et al. Uterine Artery Embolisation for Women with Giant Versus Non-giant Uterine Fibroids: A Systematic Review and Meta-analysis. Cardiovasc Intervent Radiol. 2020; 43 (5): 684–93. doi: 10.1007/s00270-019-02359-7
  12. Xu F., Deng L., Zhang L. et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. Int J Hyperthermia. 2021; 38 (2): 24–9. doi: 10.1080/02656736.2021.1933216
  13. Sandberg E.M., Tummers F.H.M.P., Cohen S.L. et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018; 109 (4): 698–707.e1. doi: 10.1016/j.fertnstert.2017.11.033
  14. Hussein A.M., Elbarmelgy R.A., Elbarmelgy R.M. et al. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder. Ultrasound Obstet Gynecol. 2022; 59 (4): 474–82. doi: 10.1002/uog.23732

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Frequency of repeated interventions after focused ultrasound ablation, uterine artery embolization and myomectomy [12]

Download (29KB)

Copyright (c) 2024 Russkiy Vrach Publishing House